Gambato, M., & Graw, F. (2019). Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis. Liver international, 39(5), . https://doi.org/10.1111/liv.14014
Chicago Style (17th ed.) CitationGambato, Martina, and Frederik Graw. "Early HCV Viral Kinetics Under DAAs May Optimize Duration of Therapy in Patients with Compensated Cirrhosis." Liver International 39, no. 5 (2019). https://doi.org/10.1111/liv.14014.
MLA (9th ed.) CitationGambato, Martina, and Frederik Graw. "Early HCV Viral Kinetics Under DAAs May Optimize Duration of Therapy in Patients with Compensated Cirrhosis." Liver International, vol. 39, no. 5, 2019, https://doi.org/10.1111/liv.14014.
Warning: These citations may not always be 100% accurate.